The effect of saffron on lipid ,FBG and depression and anxiety in patients with metabolic syndrome

Phase 3

Recruiting

• Conditions: Nutritional and metabolic disorders in diseases classified elsewhere; Metabolic Syndrome.; E70-E90

• Registration Number: IRCT20160308026961N4
• Lead Sponsor: Vice chancellor for research of Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 April 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 166

Inclusion Criteria

People with BMI = 303
No pregnancy and lactation
History of heart disease
History of fat-related diseases, and mellitus diabetes
The history of taking any type of lipid-lowering drug

Exclusion Criteria

History of systemic disease (lupus)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood fat. Timepoint: At the beginning and end of the study (eight weeks after the start of the study). Method of measurement: Based on blood tests.;Depression. Timepoint: At the beginning and end of the study (eight weeks after the start of the study). Method of measurement: Based on Beck depression inventory (BDI).;Anxiety. Timepoint: At the beginning and end of the study (eight weeks after the start of the study). Method of measurement: Based on Beck depression inventory (BDI).